Geleophysic dysplasia

Geleophysic dysplasia (also known as 'happy face' syndrome due to the characteristic pleasant facial appearance) is a rare skeletal dysplasia belonging to the group of acromelic dysplasias. It is characterized by short stature with short hands and feet, progressive joint limitations and contractures, distinctive facial features (a round 'happy' face with full cheeks, a short nose, and a thin upper lip), and skin changes including thick skin. The disease affects multiple body systems including the skeletal, cardiovascular, respiratory, and hepatic systems. Progressive cardiac valve disease, particularly affecting the aortic and mitral valves, is a major cause of morbidity and mortality and can lead to early death. Tracheal stenosis and hepatomegaly may also occur. Geleophysic dysplasia exists in at least three genetic forms. Type 1 (GPHYSD1) is caused by autosomal recessive mutations in the ADAMTSL2 gene, type 2 (GPHYSD2) by autosomal dominant mutations in the FBN1 gene (fibrillin-1), and type 3 (GPHYSD3) by autosomal recessive mutations in the LTBP3 gene. These genes are involved in the regulation of TGF-beta signaling and extracellular matrix organization, which explains the progressive nature of the connective tissue involvement. Symptoms typically become apparent in early childhood, with short stature and skeletal abnormalities often noted between ages 2 and 5 years. Radiographic findings include delayed bone age, cone-shaped epiphyses, and shortened long bones with broad metaphyses. There is currently no cure for geleophysic dysplasia. Management is multidisciplinary and focuses on surveillance and treatment of complications, particularly cardiac valve disease, which may require surgical valve replacement. Respiratory complications including tracheal stenosis require careful monitoring. Orthopedic interventions may be needed for joint contractures and skeletal deformities. Regular cardiac imaging and pulmonary function assessments are essential components of long-term follow-up. Prognosis varies but is significantly influenced by the severity of cardiac and respiratory involvement.

Common questions about Geleophysic dysplasia